<i id='95A59C9490'><strike id='95A59C9490'><tt id='95A59C9490'><pre id='95A59C9490'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Medical records are filled with copy 
FDA panel issues narrow recommendation for Covid vaccine booster doses 
Novavax promises a turnaround & Lilly roils the obesity market 
Novo pauses ads for weight loss drug Wegovy amid demand 
Psychedelics group wrestles with new pharma identity 
Anavex keeps shifting the goalposts in its clinical trials 
Drug repurposing or repositioning? The language matters 
Can medical device makers keep up in the race to treat obesity?
Novavax promises a turnaround & Lilly roils the obesity market
Novo pauses ads for weight loss drug Wegovy amid demand 
How one medical school became remarkably diverse 
Shkreli is convicted of fraud. Can pharma finally slam the door on him? 
23andMe had bad news about my health. I wish a person had delivered it 
Tennessee law changes starting July 1 will restrict trans health care and fund more school safety 
The high cost of giving birth even with insurance 